drugset / Trial / NCT01128959
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Phase 3
Completed
108 enrolled
Lundbeck LLC
ICON Clinical Research · collabLigand Pharmaceuticals · collabQuintiles, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability of intravenous (IV) carbamazepine (CBZ) administered as multiple 15 minute infusions and a single 5 minute infusion to adult patients with epilepsy on stable higher doses of oral CBZ.
Timeline
- Start
- 2010-06
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbamazepine | Small molecule | — | Intravenous |